.svg){kind=icon}
When people first learn about the endocannabinoid system, anandamide often gets much of the attention. Its nickname—the “bliss molecule”—makes it memorable.
But another naturally occurring cannabinoid-like molecule plays an equally important role in endocannabinoid signaling: 2-arachidonoylglycerol, usually shortened to 2-AG.
2-AG is an endocannabinoid, meaning the human body produces it naturally. It is not THC, CBD, or another compound supplied by cannabis.
Together with anandamide, cannabinoid receptors, and metabolic enzymes, 2-AG forms part of the biological network known as the endocannabinoid system, or ECS.
Researchers study 2-AG because it participates in communication involving the brain, nervous system, immune system, pain pathways, stress response, metabolism, and other physiological processes.
Understanding 2-AG also reinforces an important medical cannabis concept: cannabis interacts with a cannabinoid system that was already functioning long before a patient consumed THC or CBD.
What Is 2-AG?
The full name of 2-AG is 2-arachidonoylglycerol.
It is a lipid-derived signaling molecule produced naturally by the body and is considered one of the major endogenous cannabinoids.
The two best-studied endocannabinoids are:
- Anandamide, or AEA
- 2-arachidonoylglycerol, or 2-AG
Both can interact with cannabinoid receptors, but they are chemically different molecules with different concentrations, metabolic pathways, and signaling characteristics.
2-AG is generally present at considerably higher concentrations than anandamide in many tissues, particularly within the nervous system.
That does not mean it is “more important.” The two endocannabinoids perform overlapping but distinct regulatory roles.
How Does the Body Make 2-AG?
Like anandamide, 2-AG is generally produced when cells need it.
It is not simply stored in large amounts waiting to be released.
Cellular signals can activate enzymes that convert membrane-associated lipids into 2-AG.
An important step involves diacylglycerol lipase, commonly abbreviated DAGL.
The simplified pathway looks something like this:
Membrane lipids → diacylglycerol → 2-AG
Two forms of diacylglycerol lipase, DAGL-alpha and DAGL-beta, participate in 2-AG production in different tissues and biological contexts.
Once created, 2-AG can interact with nearby cannabinoid receptors and influence cellular signaling.
2-AG and CB1 Receptors
CB1 receptors are especially abundant in the brain and central nervous system.
2-AG can activate CB1 receptors and plays an important role in regulating communication between neurons.
Researchers study this signaling in connection with:
- Memory
- Movement
- Appetite
- Stress response
- Reward
- Pain processing
- Mood
- Sleep
- Learning
CB1 signaling does not simply turn these functions on or off.
Instead, 2-AG often works as part of a feedback system that helps regulate how strongly neurons communicate with one another.
2-AG as a Retrograde Messenger
One of the most interesting aspects of 2-AG biology is its role in retrograde signaling.
Most people imagine nerve communication moving in one direction: one neuron releases neurotransmitters, and another neuron receives them.
Endocannabinoid signaling can sometimes work backward.
When the receiving neuron becomes sufficiently active, it may produce 2-AG. That 2-AG travels backward across the synapse and activates CB1 receptors on the neuron that originally sent the signal.
This can reduce the amount of certain neurotransmitters being released.
In simplified terms, 2-AG can act like feedback telling the sending neuron:
“Reduce the signal for a moment.”
This process helps researchers understand how the ECS contributes to regulation rather than simply stimulation.
2-AG and CB2 Receptors
2-AG can also activate CB2 receptors.
CB2 receptors are strongly associated with immune cells and peripheral tissues, although they are also present in parts of the nervous system.
Researchers study 2-AG and CB2 signaling in relation to:
- Immune-cell communication
- Inflammatory pathways
- Tissue responses
- Neurological inflammation
- Pain-related signaling
It would be inaccurate, however, to say that 2-AG is an anti-inflammatory treatment simply because it interacts with CB2.
Immune biology is highly complex, and laboratory findings involving 2-AG do not automatically translate into a proven medical therapy.
What Breaks Down 2-AG?
Endocannabinoid signals are designed to be temporary.
After 2-AG has participated in cellular signaling, enzymes break it down.
The most important is monoacylglycerol lipase, commonly called MAGL.
MAGL converts much of the body's 2-AG into glycerol and arachidonic acid.
Other enzymes—including ABHD6 and ABHD12—also contribute to 2-AG metabolism.
This breakdown process helps regulate how long 2-AG remains active.
If 2-AG signaling continued indefinitely, the endocannabinoid system would lose some of its ability to function as a flexible regulatory network.
Why Researchers Study MAGL
Because MAGL controls a large portion of 2-AG breakdown, scientists have investigated whether changing MAGL activity could alter endocannabinoid signaling.
Experimental drugs called MAGL inhibitors can slow 2-AG degradation.
In theory, this can increase or prolong the body's own 2-AG activity.
Researchers have investigated MAGL inhibition in preclinical studies involving neurological signaling, stress, pain pathways, inflammation, and other areas.
But MAGL inhibition is not currently equivalent to standard medical cannabis treatment.
Much of this research remains experimental.
Increasing endogenous 2-AG through enzyme manipulation is also biologically different from consuming THC from cannabis.
2-AG vs. Anandamide
2-AG and anandamide are often discussed together, but patients should understand several differences.
2-AG
2-AG is generally abundant within the nervous system and can activate both CB1 and CB2 receptors.
It is produced primarily through pathways involving DAGL and is broken down mainly by MAGL.
Anandamide
Anandamide also interacts strongly with CB1 signaling but has somewhat different receptor activity and metabolic pathways.
It is primarily broken down by the enzyme FAAH.
A simple memory aid is:
Anandamide → FAAH
2-AG → MAGL
Both are endogenous cannabinoids, but the body regulates them differently.
How Is 2-AG Different From THC?
THC is a phytocannabinoid, meaning it comes from the cannabis plant.
2-AG is an endocannabinoid, meaning the body produces it naturally.
Both can activate CB1 and CB2 receptors, which helps explain why THC can influence biological pathways normally regulated by endocannabinoids.
But THC does not simply replace 2-AG.
2-AG is produced locally and temporarily in response to cellular activity.
THC enters the body from an outside source and may activate cannabinoid receptors more broadly and for a different duration.
Depending on dose, THC may influence:
- Perception
- Appetite
- Coordination
- Memory
- Mood
- Pain perception
- Heart rate
- Judgment
This is why using cannabis should not be described simply as “supplementing” the body's endocannabinoids.
What About CBD?
CBD influences the ECS differently.
It does not strongly activate CB1 receptors in the same way that THC or 2-AG can.
Instead, CBD interacts with multiple biological targets and may influence cannabinoid signaling indirectly.
Researchers continue to investigate how CBD affects endocannabinoid metabolism, receptors, ion channels, serotonin signaling, and other pathways.
CBD can also influence enzymes involved in prescription-drug metabolism.
Patients using substantial amounts of CBD should therefore discuss possible medication interactions with their physician or pharmacist.
2-AG, Stress, and the Nervous System
Researchers are particularly interested in how 2-AG signaling changes during stress.
Endocannabinoid signaling can influence communication between brain regions involved in emotional regulation, fear responses, and stress adaptation.
Preclinical research has investigated whether changes in 2-AG levels or MAGL activity could affect stress-related behavior.
That research is valuable, but it should not be interpreted as evidence that high-THC cannabis automatically improves the body's stress response.
THC dose can significantly change the experience.
Some patients may experience relaxation, while higher exposure can contribute to anxiety, rapid heart rate, paranoia, or discomfort.
Are Cannabis Terpenes Related to 2-AG?
Cannabis terpenes are not endocannabinoids.
Compounds such as:
- Myrcene
- Limonene
- Pinene
- Linalool
- Humulene
- Beta-caryophyllene
are produced by the cannabis plant.
They differ chemically from 2-AG and anandamide.
Some terpenes interact with biological pathways related to cannabinoid signaling. Beta-caryophyllene, for example, is known for interacting with CB2 receptors.
However, the terpene profile of a cannabis product does not tell patients how much 2-AG their bodies are producing.
Green Dragon Florida Products as Cannabinoid Examples
The following products contain plant-derived cannabinoids rather than 2-AG. They demonstrate how different cannabis formats can influence the ECS through external cannabinoid exposure.
They are not treatments for low 2-AG levels or recommendations for a particular medical condition.
Green Dragon Iced Grapes Flower — Jacksonville 103rd St
Iced Grapes Flower is a 3.5-gram hybrid flower currently listed at approximately 31.8% THC, 0.085% CBD, and 1.68% total terpenes.
Flower illustrates how plant-derived THC can activate some of the same cannabinoid receptors involved in natural 2-AG signaling, while still behaving very differently from an endocannabinoid produced on demand.
Fuel Piña Colada Cartridge — Coconut Creek
Fuel Piña Colada Cartridge is a 0.5-gram vaporizer cartridge currently listed at approximately 87.8% THC and 2.24% total terpenes.
Its concentrated THC content demonstrates why cannabinoid-receptor activity is strongly influenced by potency and dose.
Green Dragon Wild Strawberry Sativa Chews — Avon Park
Wild Strawberry Sativa Chews contain 100 mg of total THC per package.
Oral THC undergoes digestion and liver metabolism before producing its effects. This is very different from 2-AG, which is produced locally within the body and rapidly metabolized after signaling.
Product availability, potency, terpene profiles, and laboratory information may change by Green Dragon Florida location and batch.
The Green Dragon Takeaway
2-AG is one of the most important naturally occurring signaling molecules in the endocannabinoid system.
The body produces it on demand. It can activate CB1 and CB2 receptors, acts as an important retrograde messenger in the nervous system, and is broken down primarily by MAGL.
Alongside anandamide, 2-AG helps demonstrate why the ECS is much more than a collection of receptors waiting for cannabis.
It is an active biological network that continuously produces, uses, and removes its own cannabinoid-like signaling molecules.
THC, CBD, and other cannabis compounds can influence that network—but they are external compounds interacting with an already-functioning endogenous system.